AstraZeneca's MedImmune has received Food and Drug Administration approval for FluMist, an influenza vaccine that can be administered either by oneself or by a healthcare provider.
MTS Health Partners ("MTS") announced today that healthcare investment banker Aaron Schwimmer has joined their global life sciences practice as a Partner based in New York.